TAR DNA-binding protein 43 (TDP43) is a cause of familiar and sporadic amyotrophic lateral sclerosis (ALS). The diverse postulated mechanisms by which TDP43 mutations cause the disease are not fully understood. Human wildtype and TDP43 S393L and G294V mutant spinal motor neuron cultures were differentiated from patient-derived iPSCs. Mutant hTDP43 and wildtype motor neuron cultures did not differ in neuron differentiation capacity during early maturation stage. During aging we detected a dramatic neurodegeneration including neuron loss and pathological neurofilament abnormalities in TDP43 mutant cultures only. Additionally mitochondria and lysosomes of aging spinal motor neurons revealed robust TDP43 mutation dependent abnormal phenotypes in size, shape, speed and motility which all appeared without TDP43 mislocalization or aggregation formation. Furthermore, D-sorbitol -known to induce stress granules and cytoplasmic mislocalization of TDP43 -rescued axonal trafficking phenotypes without any signs of TDP43 mislocalization or aggregation formation. Our data indicate TDP43 mutation-dependent but cytosolic aggregation-independent mechanisms of motor neuron degeneration in TDP43 ALS.
Introduction
Worldwide 2-4 of 100.000 people per year suffer from amyotrophic lateral sclerosis (ALS) which is the most frequent variant of motor neuron disease with a survival time of 1-5 years after symptom onset. Motor neurons are the mainly affected cell type that undergoes degeneration and death in ALS 1, 2 . Several gene mutations were found to cause familiar forms of ALS (fALS) of which the first identified were SOD1 (superoxide dismutase 1) gene mutations in 1993 3, 4 . In 2006 mutations in TDP43 (TAR DNA binding protein, TDP43) were identified to cause fALS as well as sporadic ALS but the pathophysiology caused by mutant TDP43 is still not fully understood 5 . Most importantly, TDP43 is the main aggregating protein in sporadic ALS also being aggregated in some fALS forms (e.g. TDP43, C9ORF72) 6 .
However, TDP43-mediated pathophysiology appears to be mechanistically distinct from mutant SOD1 action 7 .
Different mechanisms for TDP43 mutant pathology have been suggested (for review see Jovicic) . These include nuclear loss of function leading to transcription and splicing defects, toxic properties in the cytoplasm sequestering RNAs and RNA binding proteins and finally loss of axonal transport function with RNA granule transport deficiencies 8 . The main focus has been drawn on pathological accumulation of cytosolic TDP43 [9] [10] [11] . Mutant TDP43 human induced pluripotent stem cell (hiPSC)-derived neurons were reported to show elevated levels of soluble and detergent-resistant TDP43 protein and decreased survival in long-term differentiation 12 .
Such lines showed a two-fold increase in cytosolic TDP43 compared to the controls which could be -at least partially -reduced by 30% by allele-specific knockdown 13 . However, on a closer look, also in models reporting cytosolic mislocalization of TDP43, only up to one third of cells showed this phenotype while the remaining cells still showed physiological nuclear TDP43 10, 11, 14 .
TDP43 was shown to be actively transported within the axon in both directions 14 . TDP43 thereby forms cytoplasmic mRNP granules that undergo bidirectional, microtubule-dependent transport in neurons and facilitate delivery of target mRNA to distal neuronal compartments 15 .
TDP43 mutations interfere with mRNA transport function 14, 15 . Neurofilament light chain (NEFL) mRNA was shown to be transported in such TDP43 granules and was reduced in TDP43 mutant motor neurons 10, 15 .
ALS-linked mutations in TDP43 can impair stress granule dynamics 16 . TDP43 had previously been shown to associate with multiple proteins that are part of mRNP granules (e.g., staufen, FMRP, SMN, and HuD), including neuronal transport granules 17 . TDP43 was shown to be directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor 18 and to regulate FOXO-dependent protein quality control in stress response 19 .
Mutations in TDP43 led to abnormal 9 or reduced neurite outgrowth 20, 21 . TDP43 mice model shows lack of mitochondria in motor axon terminals 10 . Furthermore, TDP43 was reported to impair mitochondria and lysosome morphology and function in cell models of ALS.
Interestingly, both overexpression and knockdown caused perturbations in primary murine neurons suggesting a tight regulation of TDP43 22, 23 . Overexpression of wildtype or mutant TDP43 caused mitochondrial shortening in dendrites, not in axons, due to increased fission and decreased mitochondrial movement in axons and dendrites. In contrast, knockdown increased mitochondrial length but also decreased dendritic and axonal mitochondrial motility. Mt TDP43 caused co-staining of mitochondria and TDP43, which was rescued by Mfn2 expression.
However, the relation between (stress induced) cytoplasmic TDP43 aggregation and neuronal dysfunction and degeneration remains enigmatic. Furthermore, data on organelle trafficking and neurite morphology in human patient-derived motor neurons are still lacking.
This prompted us to use patient-derived induced pluripotent stem cells (hiPSCs)-derived motor neurons to investigate (i) the sequential appearance of neuronal dysfunction and neurodegeneration, (ii) aggregate formation and (iii) how these events are mechanistically connected. Surprisingly, we found significant neuronal dysfunction and degeneration during cellular aging, but did not find relevant signs of pathological TDP43 aggregation, arguing against an upstream function of TDP43 aggregation in TDP43-ALS.
Materials and Methods

Patient characteristics
We included cell lines carrying a "benign" (S393L, late onset primary anarthria with ALS/LMND, no clinical symptoms of FTD, female, family history of ALS and PD) and a "malign" (G294V, early onset ALS, no clinical symptoms of FTD, male, no family history) TDP43 mutation and were compared to four wildtype cell lines from healthy volunteers (female, age at biopsy 45; female, age at biopsy 53; male, age at biopsy 60 24, 25 ). An overview of the used cell lines is demonstrated in Supplemental Table S1 . The performed procedures were in accordance with the Helsinki convention and approved by the Ethical Committee of the University of Dresden (EK45022009; EK393122012). Informed consent was obtained from any individual including informed consent about publishing data obtained from the iPSCs derived from skin fibroblasts. The skin biopsies (see below) were obtained after anonymisation.
Generation of iPSC lines
For generating iPSC lines fibroblast lines were established from skin biopsies taken from familial ALS patients and healthy controls. The generation and characterization of wildtype iPSC lines was reported previously 24, [26] [27] [28] . Briefly, patient fibroblasts were reprogrammed using pMXbased retroviral vectors encoding the human cDNAs of OCT4, SOX2, KLF4 and cMYC (pMX vectors). Vectors were co-transfected with packaging-defective helper plasmids into 293T cells using Fugene 6 transfection reagent (Roche Diagnostics). Fibroblasts were plated at a density of 50,000 cells/well on 0.1% gelatin-coated 6-well plates and infected three times with a viral cocktail containing vectors expressing OCT4:SOX2:KLF4:cMYC in a 2:1:1:1 ratio in presence of 6 µg/ml protamine sulfate (Sigma Aldrich) and 5 ng/ml FGF2 (Peprotech). Infected fibroblasts were plated onto mitomycin C (MMC, Tocris) inactivated CF-1 mouse embryonic fibroblasts (in-lab preparation) at a density of 900 cells/cm2 in fibroblast media. The next day media was exchanged to ES medium containing 78% Knock-out DMEM, 20% Knock-out serum replacement, 1% non-essential amino acids, 1% penicillin/streptomycin/glutamine and 50µM β -Mercaptoethanol (all from Invitrogen) supplemented with 5 ng/ml FGF2 and 1 mM valporic acid (Sigma Aldrich). Media was changed every day to the same conditions. iPSC-like clusters started to appear at day 7 post infection, were manually picked 14 days post-infection and plated onto Genotyping TDP43 iPSC lines were genotyped after all other characterization had been finished. This was done by a diagnostic human genetic laboratory (CEGAT, Tübingen, Germany) using diagnostic standards.
Differentiation of human NPCs to spinal motor neurons
The generation of human NPCs and motor neurons was accomplished following the protocol from Reinhardt et al. 26 . In brief colonies of iPSCs were collected and stem cell medium was added containing 10µM SB-431542, 1µM Dorsomorphin, 3µM CHIR 99021 and 0.5µM purmorphamine 29 to split them at a ratio of 1:10 -1:20 once a week using Accutase for 10 min at 37°C.
Final motor neuron differentiation was induced by treatment with 1µM PMA in N2B27 exclusively. After 2 days 1µM retinoic acid (RA) was added. On day 9 another split step was performed to seed them on a desired cell culture system. Furthermore the medium was modified to induce neuronal maturation. For this purpose the developing neurons were treated with N2B27 containing 10 ng/ µl BDNF, 500 µM dbcAMP and 10 ng/ µl GDNF. Following this protocol it was possible to keep the cells in culture for over 2 months. The cells were analyzed at day 5 and day 32 post maturation induction by immunofluorescence imaging.
Immunofluorescence of spinal motor neurons
For immunofluorescence staining, cells were washed twice with PBS without Ca2 + /Mg2 + (LifeTechnologies) and fixed with 4% PFA in PBS for 15 min at RT. PFA was aspirated and cells were washed three times with PBS. Fixed cells were first permeabilized for 10 minutes in 0.2 % Triton X solution and subsequently incubated for 1 hour at RT in blocking solution (5% donkey serum in PBS). Following blocking, primary antibodies were diluted in PBS and cells were incubated with primary antibody solution overnight at 4°C. The following primary antibodies were used: chicken anti-SMI32 (1:10000, Covance), rabbit anti-beta-III-Tubulin
(1:3000, Covance), rabbit anti-CHAT (1:1500, Chemicon), mouse anti-MAP2 (1:500, BD Biosciences). Post to the primary antibodies cells were washed three times for 5 min with PBS.
Secondary antibodies were diluted in PBS and incubated with the cells for 1.5 hours at RT.
Following secondary antibodies were used: donkey anti-chicken IgY FITC (1:500, Merck Millipore), donkey anti-rabbit IgG647 (1:500, Life Technologies), donkey anti-rabbit IgG488
(1:500, Life Technologies) and donkey anti-mouse IgG555 (1:500, Life Technologies). Nuclei were counter stained using Hoechst (LifeTechnologies).
Microfluidic chambers
The MFCs were purchased from Xona (RD900). At first, Nunc glass bottom dishes with an inner diameter of 27 mm were coated with Poly-L-Ornithin over night at 37°C. Following 3 washing steps with sterile water they were kept under the sterile hood to dry out completely.
MFCs were sterilized with 70% Ethanol and also left drying. Next the MFCs were dropped on the glass bottom dishes and carefully pressed on the surface. Properly attached the system was then perfused with 0.01 mg/ ml Laminin in PBS. After another 1h at 37° and one washing step with medium it could be used for cell culture. For seeding cells into this system, the entire volume was soaked out and 10µl containing a high concentration of cells (15x10^6 cells/ ml) were directly injected into the main channel connecting two wells. After allowing attachment for half an hour in the incubator, the still empty wells were filled up with maturation medium.
This method grants the possibility to enhance the amount of neurons growing in main channels while the wells stay free of them which reduces the medium turnover to a minimum. To avoid drying out PBS was added around the MFCs. Two days later the medium was replaced in a manner which should give the neurons a guidance cue to grow through the microchannels. nm). Movie acquisition was performed at strictly standardized readout positions within the micro channels of the micro groove barrier that separated the proximal seeding site from the distal axonal exit. Specifically, the readout windows were located either just adjacent to the channel exit (distal readout) or the channel entry (proximal readout).
Tracking analysis
Movies were analyzed with FIJI software using the TrackMate v2. Contrast...", "saturated=0.1 normalize"); run("Tubeness", "sigma=0.4 use"); run("Enhance Contrast...", "saturated=0.1 normalize"); run("8-bit"); setAutoThreshold("Triangle dark"); run("Convert to Mask"); run("Skeletonize (2D/3D)"); run("Set Measurements...", "area redirect=None decimal=5"); run("Create Selection"); run("Measure"); saveAs("Measurements", path+name+" network.txt"); selectWindow(name); run("Slice Keeper", "first=1 last=1 increment=1"); run("Select All"); run("Set Measurements...", "kurtosis redirect=None decimal=5"); run("Clear Results"); run("Measure"); saveAs("Measurements", path+name+" Kurtosis.txt"); run("Grays"); run("Enhance Contrast...", "saturated=0.1 normalize"); run("Subtract Background...", "rolling=3"); setAutoThreshold("Moments dark"); run("Threshold..."); run("Convert to Mask"); run("Set Measurements...", "area fit shape feret's integrated area_fraction limit redirect=None decimal=5"); run("Clear Results"); run("Analyze Particles...", "size=4-Infinity pixel circularity=0.00-1.00 show=Ellipses clear display") and Macro2 for lysosomes: run("Clear Results"); run("Slice Keeper", "first=1 last=1 increment=1"); run("Grays"); run("Enhance Contrast...", "saturated=0.1 normalize"); run("Subtract Background...", "rolling=5"); setAutoThreshold("Moments dark"); run("Threshold..."); run("Convert to Mask"); run("Set Measurements...", "area fit shape feret's integrated area_fraction limit redirect=None decimal=5"); run("Analyze Particles...", "size=3-Infinity pixel circularity=0.00-1.00 show=Ellipses clear display")
These macros returned result tables containing the aspect ratio of fitted eclipses (long:short radius) that was taken as measure for mitochondrial elongation as well as the outer Feret's diameter that was taken as lysosomal diameter. The same set of movies as for the tracking analysis (see above) was used (first frame only). Typically, hundreds of organelles were analyzed per movie. For bulk statistics, the same batch analysis as for the tracking analysis was performed with resultant distributions displayed as box plots.
Electrophysiology
We performed patch-clamp recordings as described previously 30 Supplemental Tables 2-9 .
Results
Motor neuron differentiation is not affected by ALS-causing TDP43 mutations
In order to confirm the neuronal differentiation potential and ensure that wildtype and TDP43 mutant motor neuron cultures exhibit the same differentiation capacity for further disease modeling, they were analyzed towards the proportion of neuron types, their morphology and their survival rates during motoneuronal differentiation. For this, iPSCs were derived from two different patients and three different control individuals (different families with different mutations; G294V; S393L, respectively; different controls from different families, see also
Suppl. Table 1 ). A defined cell number of patient NPCs (neural progenitor cells) were differentiated for 9 days and subsequently seeded for the final motor neuron maturation process for 5 additional days (Figure 1 A, Together the early motor neuron maturation analysis showed an efficient homogeneous neuron differentiation with a high spinal motor neuron differentiation potential (SMI32 + /CHAT + , Figure   1 C) in all analyzed motor neuron cultures.
Furthermore, both, wildtype and TDP43 mutant iPSC-derived motor neurons acquired normal neuronal function such as sodium and potassium currents (Figure 2 A-D), single and repetitive action potentials (Figure 2 E, F) as well as spontaneous postsynaptic currents (G-I) with no significant differences between healthy and TDP43 mutant motor neurons.
Mutant TDP43 motor neurons show age-related disturbed distal axonal organelle morphology
During aging mitochondria and lysosomes were visualized by Mito-and Lysotracker labelling of motor neuron cultures in directed microfluidic chambers (MFCs) at 2 and 4 weeks of maturation/aging (Figure 1 A & 3 A, B) . Tables 2 and 3 ). Together, the size of the majority of mitochondria and lysosomes were exclusively affected at distal axon sites of aged TDP43 mutant motor neuron cultures.
Next, we investigated mitochondrial and lysosomal shape (Figure 3 H, I). Our analysis of the mitochondrial aspect ratio (AR; indicates the shape ranging from round (AR=1) to elongated (AR>1) morphologies; long:short radius) revealed diverse phenotypes differing from proximal to distal axon sites (Figure 3 H) . At proximal axons, we observed a mitochondrial shortening from young to aged cultures in both wildtype and TDP43 mutants that was also present in distal axons of wildtype neurons (proximal: 2.34±0.03, P<0.0001; distal: 2.54±0.03, P=0.003; Detailed statistics are presented in Suppl. Table 4 ). Taken together, the majority of mitochondria of TDP43 mutant MFC cultures revealed a global phenotype of imbalanced shape properties when proximal and distal axon sites were compared and in contrast to wildtype they got elongated during aging.
Furthermore, analyzing the Feret diameter of lysosomes (i.e. the diameter of the outer organelle's perimeter) revealed a significant proximal decrease in TDP43 mutant motor neurons from young to aged stages as opposed to the increase in the wildtype during the same time.
( Figure 3 I; detailed statistics are provided in Suppl. Table 5 ). Conversely, at the distal end we revealed a more vague trend towards smaller lysosome diameters in all lines.
TDP43 mutant motor neurons show a dramatic loss of organelle motility during aging
The motility of mitochondria and lysosomes is a critical property especially in neurons since it mainly determines the energy supply and cellular waste removal of cells. We analyzed the organelle mean speed and the extent of organelle displacement in MFC motor neuron cultures and identified a drastic global (i.e. at either proximal and distal site) axonal transport deficiency in TDP43 mutants in aging but not young motor neurons (Figure 4 A; Suppl. Videos 1 & 2).
In detail, mitochondria of TDP43 mutant neurons exhibited a drastic slow-down of mitochondrial mean speed at proximal and distal axons during aging (Figure 4 A, B ; Suppl. Videos 1, 2; Suppl. Table 6 ). Consistently, we revealed a decrease of mitochondrial displacement (=extent of movement radius, measure for processivity in motility) (Figure 4 D, for detailed statistics see Suppl. Table 6 ; 8).
The analysis of lysosomal mean speed uncovered similar trafficking defects (Suppl. Videos 1;
2): lysosomes of TDP43 mutant neurons significantly decreased their mean speed (Figure 4 A, C) and displacement (Figure 4 E, for detailed statistics see Suppl. Table 7 , 9) at both axon sites during aging. Overall, our data indicate a gross decrease of mitochondrial and lysosomal organelle motility during aging at both distal and proximal axons in TDP43 mutant motor neurons.
Aged TDP43 mutant motor neuron cultures show increased neuron death without signs of TDP43 protein aggregation formation
The neuronal homogeneity during the early neuron maturation stage (Figure 1 (Figure 1 D) . Wildtype as well as TDP43 mutant cells showed a dominant nuclear localization of TDP43 protein and no detectable phosphorylated TDP43(Supplemental Figure 1) .
TDP43 mutant neurons show dramatic axo-skeletal degeneration during aging
The analysis of cytoskeletal alterations during neuronal aging revealed dramatic differences between wildtype and TDP43 mutant motor neuron cultures ( 
D-Sorbitol rescues mutant TDP43 motor neuron organelle morphology and motility without inducing TDP43 aggregation
Osmolytes are small organic compounds that affect protein stability and are ubiquitous in living systems. D-sorbitol is known as protein protecting and stabilizing osmolyte 31 . Furthermore, Dsorbitol was reported to recruit TDP43 to stress granules 18 , to induce cytoplasmic mislocalization and to interfere with the quality control machinery in TDP43 mutants 19 . To Tables 2 -9 ).
Discussion
Here we show age-dependent neurodegeneration of patient-derived TDP43 mutant motor neurons similar to Bilican and colleagues 12 . Furthermore, we present substantial data arguing against TDP43 aggregation as upstream event in the pathophysiology of TDP43-ALS. Initially, morphologically healthy appearing motor neurons (Figure 1 , similarly reported in 11 ) revealed robust TDP43-mutation-dependent abnormal phenotypes of mitochondria and lysosomes (Figures 3, 4, 6 ) and the cytoskeleton ( Figure 5 ) during aging without signs of cytoplasmic TDP43 aggregation (Figures 1, 5 ).
Since the first description of a motor neuron disease a well-known hallmark in the pathology is progressive motor neuron degeneration in the spinal cord 32 and, by modern neuropathology techniques, pathogenic TDP43 aggregation in motor neurons of ALS and FTLD 5, 33 and other neurodegenerative disorders 34 . In this study, we document pathological degeneration of in vitro cultivated patient-derived (iPSCs) spinal motor neurons of TDP43 mutation carriers characterized by dramatic neuron and spinal motor neuron loss during aging and the formation of severely abnormal cytoskeletal structures in mutant cultures ( Figure 5 ). In contrast, we could not observe cytoplasmic TDP43 localization or aggregation in aged neurons and spinal motor neurons (Figure 1, 5 ) assuming a TDP43 protein mislocalization-independent mechanism of neurodegeneration. We cannot rule out that the mutations used in the current study behave slightly different to other TDP43 mutations 35 . However, our data is not in contrast to recent studies reporting cytosolic mislocalization of TDP43 since, on a closer look, also in these models suing different TDP43 mutations only up to one third of cells showed cytosolic mislocalization while the remaining cells still showed physiological nuclear TDP43 10, 11, 14 .
Surprisingly, we could not detect relevant cytoplasmic TDP43 mislocalization or aggregation even after treatment with the osmolyte D-sorbitol being reported to induce stress granules formation and cytoplasmic mislocalization of TDP43 18 . Furthermore, D-sorbitol rescued organelle morphology and motility in TDP43 mutant patient-derived neurons ( Figure 5 ).
Neurite outgrowth was reported being reduced in murine models of TDP43 9,20 which could be restored by non-toxic proteasome inhibition 20 . D-sorbitol is known as protein protecting and stabilizing osmolyte 31 . This could explain our rather unexpected results showing that the osmolyte sorbitol leads to restoration of the axon trafficking phenotype. Together, both results argue against a TDP43 aggregation-dependent mechanism as early event in neurodegeneration of TDP43 motor neuron degeneration.
The size of the majority of mitochondria and lysosomes was mainly affected at distal axon parts (directed to axon endings) indicated by elongated mitochondria and shrunken lysosomes in comparison to wildtype cases (Figure 3 & 6 ). Furthermore, we detected in aged but not young TDP43 mutant motor neurons an overall organelle trafficking deficit (Figure 4 & 6) . This is in accordance with TDP43 mice model data showing lack of mitochondria in motor axon terminals 10 . Furthermore, TDP43 was reported to impair mitochondria and lysosome morphology and function in cell models of ALS. Interestingly, both overexpression and knockdown caused a phenotype in primary murine neurons suggesting a tight regulation of TDP43 22, 23 .
TDP43 was shown to be actively transported in the axon thereby forming cytoplasmic mRNP granules that undergo bidirectional, microtubule-dependent transport in neurons and facilitate delivery of target mRNA to distal neuronal compartments 14, 15 . TDP43 mutations impair this mRNA transport function 14, 15 . Several lines of evidence suggest that mRNA encoding cytoskeletal proteins is cargo of such mRNA-transporting proteins being locally translated in the distal axon 36,37 . For instance, neurofilament light chain (NEFL) mRNA was shown to be transported in such TDP43 granules and was reduced in TDP43 mutant motor neurons 10, 15 . These data fit to our observations of severely disturbed cytoskeletal proteins such as tubulin, microtubules and neurofilaments. Furthermore, this could induce a vicious cycle by additionally impairing microtubule-dependent mRNP granule transport 14, 15 .
Together, we here report typical age-related motor neurodegeneration in TDP43 mutant ALS patient-derived motor neurons leading to a severe organelle transport deficiency, cytoskeletal disturbance and neurodegeneration without TDP43 protein mislocalization or aggregation formation. This challenges the current concept of protein aggregation as the main cause of motor neuron disease pathology and calls for a search for therapeutic targets independent of TDP43 aggregation.
Conclusions
We here show aging-related neurodegeneration in patient specific TDP43 mutant iPSC-derived motor neuron cultures. Cell organelles as mitochondria and lysosomes showed TDP43 mutation dependent abnormalities in size, shape, speed and motility which all appeared without TDP43 mislocalization or aggregation formation. Finally, D-sorbitol -known to induce stress granules and cytoplasmic mislocalization of TDP43 -rescued axonal trafficking phenotypes without any signs of TDP43 mislocalization or aggregation formation. Our data suggest TDP43 mutationdependent but cytosolic aggregation -independent mechanisms of motor neuron degeneration in TDP43 ALS. 
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